Kidney Cancer Treatment Options
Kidney cancer treatment is not one-size-fits-all: the right approach depends on the tumor’s type and stage along with the patient’s overall health. Understanding today’s range of options can help patients and their families work with their care team toward a plan that fits their situation.
Key Takeaways
- Kidney cancer treatment is planned around the specific type and stage of the disease along with the patient’s overall health, rather than a single standard approach.
- Most adult kidney cancer is renal cell carcinoma; tumors of the renal pelvis or ureter, and Wilms tumor in children, follow their own separate treatment path.
- When kidney cancer hasn’t spread beyond the kidney, an operation called nephrectomy — taking out the tumor with some or all of the surrounding kidney tissue — is generally how it is treated; ablation or embolization are options for patients who cannot have surgery.
- Once the disease reaches beyond the kidney, treatment usually shifts toward targeted therapy or immunotherapy rather than the chemotherapy used for many other cancer types.
- Managing side effects and considering clinical trials are both part of a complete kidney cancer treatment plan.
Overview of Kidney Cancer Treatment Options
Kidney cancer is not treated with a single standard approach. A care team builds a plan around the cancer’s specific type together with the patient’s general health and personal preferences, and the plan may combine more than one type of treatment. Adult kidney cancer is overwhelmingly renal cell carcinoma, so the information below centers on how that type is managed. Tumors that begin in the renal pelvis or ureter, along with Wilms tumor and other childhood kidney cancers, fall into their own separate treatment categories and are not covered here in detail.
Initial Assessment and Staging
Diagnosis typically starts with imaging — ultrasound, CT, or MRI — and sometimes a biopsy to pin down the exact type of cancer. After a kidney cancer diagnosis, additional tests, part of a process called staging, determine how far the disease reaches beyond the kidney and whether it has moved into other areas of the body. Knowing the stage is central to planning treatment, and prognosis and treatment options depend mainly on the stage of the disease along with the patient’s age and general health. A closer look at how each stage is defined and treated is available in Massive Bio’s dedicated resource on kidney cancer stages.
Personalized Treatment Planning
A cancer care team works with the patient to settle on a treatment plan, weighing the expected benefits of each option against its risks and possible side effects. Before starting treatment, some patients choose to get a second opinion on their diagnosis and plan, sharing pathology reports, slides, and scans with another doctor for review. Personal preferences and goals of care matter too, since the right choice should reflect what matters most to the patient alongside the medical recommendation.
Common Kidney Cancer Therapies
Kidney cancer treatment relies on a mix of surgical and systemic approaches, chosen according to whether the cancer is confined to the kidney or has spread beyond it.
Surgical Interventions
When kidney cancer stays within the kidney, doctors generally turn to nephrectomy, an operation to take out the tumor along with some or all of the surrounding kidney. How much tissue comes out depends on the approach: a partial nephrectomy takes out just the tumor and a rim of healthy tissue around it, an option favored when keeping kidney function matters most, for instance if the other kidney is impaired or already gone. A simple nephrectomy takes the kidney by itself, and a radical nephrectomy goes further, also removing the adrenal gland, nearby fatty tissue, and typically the lymph nodes closest to the kidney. If both kidneys are removed or stop working, dialysis or a kidney transplant becomes necessary. When surgery is not possible, other options include arterial embolization, which cuts off blood flow to the tumor to help shrink it, and ablation techniques such as cryotherapy (freezing) or thermal ablation (heat). Radiation, most often given as external beam radiation therapy, can ease symptoms and support day-to-day well-being once the disease has spread beyond the kidney; a more precise technique known as stereotactic ablative body radiation therapy is sometimes used instead.
Systemic Therapies (Targeted, Immunotherapy)
Chemotherapy, a mainstay for many other cancers, is not among the treatment types the National Cancer Institute lists for kidney cancer; targeted therapy and immunotherapy take on that systemic role instead once the disease has spread beyond the kidney. Targeted therapy drugs used for kidney cancer, including axitinib, cabozantinib, everolimus, lenvatinib, and tivozanib, work by blocking the molecular signals tumors depend on: some cut off the new blood supply a tumor needs to keep growing, while others interrupt the growth signals cancer cells rely on directly. Immunotherapy drugs used for kidney cancer, including ipilimumab, nivolumab, pembrolizumab, interleukin-2, and interferon, take a different approach; rather than acting on the tumor directly, they are designed to strengthen the body’s own defenses against it, and they may be given alone or in combination.
Factors Guiding Treatment Decisions
Choosing among these options means weighing the cancer itself against the person being treated, since no single treatment fits every case.
Cancer Stage and Type
The stage of kidney cancer at diagnosis, along with the specific cancer type, shapes which treatments are considered appropriate. A doctor may also suggest biomarker testing to help predict how well a particular targeted therapy or immunotherapy drug is likely to work for an individual tumor, supporting a more tailored choice among the available options.
Patient Health and Preferences
Beyond the cancer’s stage and type, a patient’s age and general health influence which treatments are appropriate and how well they may be tolerated. Preferences matter as well: some patients may lean toward a more aggressive approach, while others prioritize a plan with a gentler impact on daily life, and the care team factors this in alongside the medical picture.
Emerging Therapies for Kidney Cancer
Research into kidney cancer treatment continues, and this page focuses mainly on the approaches already established in clinical practice.
Clinical Trials and Innovations
New treatments and drug combinations for kidney cancer are tested in clinical trials, which can give eligible patients access to approaches not yet widely available. Some trials test new treatments directly, while supportive care and palliative care trials study ways to ease side effects and improve quality of life during treatment.
Future Directions in Treatment
Biomarker testing, described above, is one way treatment is becoming more individualized for kidney cancer. Readers who want a closer look at other experimental approaches can find one in Massive Bio’s dedicated kidney cancer research resource.
Managing Treatment Side Effects
Kidney cancer treatment can cause side effects that vary depending on which treatment, or combination of treatments, a patient receives.
Common Adverse Reactions
What side effects look like depends on the specific treatment received, and the surgical team can explain what to expect from a given procedure beforehand. Diarrhea and liver-related problems are the side effects targeted therapy causes most often, and high blood pressure or fatigue can also develop in some patients. Immunotherapy commonly causes rash, diarrhea, or fatigue; less often it triggers inflammation in other organs, since it works by changing how the immune system behaves rather than acting on the tumor directly.
Supportive Care Strategies
Medicines can often prevent or treat targeted therapy side effects such as diarrhea or high blood pressure, and most targeted therapy side effects resolve once treatment ends. Patients are encouraged to tell their care team about new or worsening symptoms promptly, since staying on top of side effects is an ongoing part of the treatment plan rather than a separate concern. Massive Bio’s dedicated resource on managing kidney cancer treatment side effects goes into this in more depth.
Frequently Asked Questions
What is the primary goal of kidney cancer treatment?
The goal depends on how far the cancer has spread. For disease confined to the kidney, treatment generally aims to remove the cancer; for advanced or metastatic disease, the focus shifts toward controlling growth, relieving symptoms, and supporting quality of life. Every plan is built around the specific case rather than a fixed formula.
How do doctors decide on the best treatment plan?
Doctors weigh the cancer’s stage and type against the patient’s age, general health, and preferences, then work through the options together as a care team. Getting a second opinion before starting treatment is also a reasonable step for many patients.
Are there any non-surgical options for early-stage kidney cancer?
Yes. When surgery is not a good option, doctors may use arterial embolization to cut off the tumor’s blood supply, or ablation techniques such as cryotherapy or thermal ablation to destroy it directly. These approaches are generally considered for smaller tumors or for patients who cannot safely undergo surgery.
Sources
